Episode: 201 - Stacy Enxing Seng on Why People and Culture Determine Medtech
Meeting the right people can completely change the trajectory of one’s career. In this episode of Medtech Talk, host Geoff Pardo speaks with Stacy Enxing Seng, independent director and venture partner, about her journey from Harvard Business School to SciMed to ev3 and beyond. She delves into the lessons learned, the challenges, and—most importantly—the people that have impacted her illustrious career. She also shares advice on why soft skills are key to acquisitions and integrations, the importance of transparency, and determining the difference between a CEO who isn’t the right fit versus a CEO who has room to grow. Medtech Talk Links: Cambridge Healthtech Institute Medtech Talk Gilde Healthcare Corza Medical Lightstone Ventures
--------
1:02:35
--------
1:02:35
Episode: 200 - Ridhi Tariyal on Bridging the Data Gap in Women’s Health
The data gap in women’s health has always been a major issue and challenge. Ridhi Tariyal, CEO and co-founder of NextGen Jane, is on a mission to de-risk the women’s health field and fill in the blanks with critical information and research. Host Swaril Mathur speaks with Tariyal on how NextGen Jane is collecting data through menstrual blood to make diagnoses and treatments easier. Tariyal also shares advice on the pros and cons of going the cash-pay consumer route and pitching the right business proposal to gain investors’ attention, as well as NextGen’s plans and focus points. Medtech Talk Links: Cambridge Healthtech Institute Medtech Talk Gilde Healthcare MicroTransponderLinks: MicroTransponder NextGen Jane: NextGen Jane
--------
46:55
--------
46:55
From Boston Scientific to Entrepreneur: Chas McKhann’s Medtech Journey
From consulting to working at large companies to taking a risk with start-ups to becoming Silk Road Medical’s CEO, Chas McKhann has experienced almost everything in his long and illustrious career. In a discussion with Medtech Talk host Geoff Pardo, McKhann shares all the lessons learned from his jump to small private companies, handling a cultural rebirth as a newcomer CEO under the public eye, and taking on his role at Silk Road. He also talks about the “what if’s” of his journey and tips on surviving in the industry, as well as witnessing the market shift from only caring about revenue to wanting to see the path to capital break even. LINKS: Medtech Talk Links: Cambridge Healthtech Institute Medtech Talk Gilde Healthcare Silk Road Medical: Silk Road Medical
--------
59:35
--------
59:35
Innovating for Niche Populations with Eric Chehab and James Wall
Niche markets and small populations don’t get the attention they need for medtech and healthcare. Medtech Talk host Swaril Mathur speaks with Eric Chehab, founder and former CEO of Novonate and director of business development of Laborie OB/GYN/NICU, and James Wall, pediatric surgeon and founder of Impact1 at Stanford University, about how they’re bringing medtech innovation to small patient populations. They delve into their experiences of founding their own niche market companies and the lessons learned, including how they navigated commercialization and acquisition processes, convinced the right investors, determined capital efficiency, and more. They also share their thoughts on investors who think niche solutions for niche markets are uninteresting. Medtech Talk Links: Cambridge Healthtech Institute Medtech Talk Gilde Healthcare MicroTransponderLinks: MicroTransponder Stanford University Links: Stanford Healthcare Stanford Medicine Children’s Health Stanford University Laborie Links: Laborie
--------
50:04
--------
50:04
Episode: 197 - Fireside Chat: How Michael Mahoney Built a Culture of Disciplined Innovation at Boston Scientific
Live from Medtech MVP, Michael Mahoney, chairman and CEO of Boston Scientific Corp, sits down with Medtech Talk podcast host Justin Klein. They discuss Mahoney’s communications strategies to align expectations and convey intentions to shareholders, how to delegate and streamline decision making, and advice on doing better as a partner. Mahoney also shares which second order considerations (such as manufacturing) are important to keep in mind, as well as whether he’s a “war time” or “peace time” CEO and what challenges the industry needs to address today to create a better tomorrow. Medtech Talk Links: Cambridge Healthtech Institute Medtech Talk Gilde Healthcare Boston Scientific Corp: Boston Scientific Corp
Colombia